Press release
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Chronic Myeloid Leukemia (CML) Treatment Market
Chronic Myeloid Leukemia (CML) Treatment Market
Projected Market Size and Growth Rate in Chronic Myeloid Leukemia Treatment
The chronic myeloid leukemia treatment market is anticipated to expand significantly in the coming years, reaching a value of $12.17 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 7.2%. Factors contributing to this upward trend include the ongoing development of innovative targeted therapies, greater adoption of combination treatments, and the increased focus on precision oncology programs. Additionally, efforts to improve treatment adherence and rising investments in oncology research are driving this expansion. Key trends expected to influence the market include broader uptake of targeted therapy regimens, enhanced use of next-generation tyrosine kinase inhibitors (TKIs), growing emphasis on molecular diagnostics, the rise of personalized treatment plans, and a strengthened focus on managing the disease in the long term.
Download a free sample of the chronic myeloid leukemia (cml) treatment market report:
https://www.thebusinessresearchcompany.com/report/chronic-myeloid-leukemia-cml-treatment-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Top Companies Leading the Chronic Myeloid Leukemia Treatment Industry
Several prominent pharmaceutical and biotech companies are major contributors to the chronic myeloid leukemia treatment market. These include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co. Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Incyte Corporation, Cipla Limited, Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals LLC, Lupin Limited, Innovent Biologics Inc., Glenmark Pharmaceuticals Limited, Il-Yang Pharmaceutical Co. Ltd., Accord Healthcare Inc., ARIAD Pharmaceuticals Inc., Orca Bio, and Bio-Path Holdings Inc.
Recent Strategic Moves Enhancing Market Competitiveness
In January 2025, Handa Therapeutics, a US-based pharmaceutical company, expanded its portfolio by acquiring the FDA-approved CML drug PHYRAGO (dasatinib) tablets for an undisclosed sum. This acquisition aims to strengthen Handa Therapeutics' position in oncology, particularly in hematologic malignancies, by broadening access to targeted therapies. The move is also expected to accelerate revenue growth through a product that has regulatory approval and an established market presence. Another notable player in the space is Nanocopoeia, LLC, a US-based research firm contributing to advancements in the field.
The market for chronic myeloid leukemia (CML) treatments is on a promising trajectory, reflecting notable advancements in medical therapies and research. As new targeted drugs and personalized treatment approaches gain traction, this sector is set to experience substantial growth. Below is an in-depth look at the market size, key players, emerging trends, and product segments shaping the future of CML treatment.
Projected Market Size and Growth Rate in Chronic Myeloid Leukemia Treatment
The chronic myeloid leukemia treatment market is anticipated to expand significantly in the coming years, reaching a value of $12.17 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 7.2%. Factors contributing to this upward trend include the ongoing development of innovative targeted therapies, greater adoption of combination treatments, and the increased focus on precision oncology programs. Additionally, efforts to improve treatment adherence and rising investments in oncology research are driving this expansion. Key trends expected to influence the market include broader uptake of targeted therapy regimens, enhanced use of next-generation tyrosine kinase inhibitors (TKIs), growing emphasis on molecular diagnostics, the rise of personalized treatment plans, and a strengthened focus on managing the disease in the long term.
Download a free sample of the chronic myeloid leukemia (cml) treatment market report:
https://www.thebusinessresearchcompany.com/report/chronic-myeloid-leukemia-cml-treatment-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Apr_PR
Top Companies Leading the Chronic Myeloid Leukemia Treatment Industry
Several prominent pharmaceutical and biotech companies are major contributors to the chronic myeloid leukemia treatment market. These include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co. Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Incyte Corporation, Cipla Limited, Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals LLC, Lupin Limited, Innovent Biologics Inc., Glenmark Pharmaceuticals Limited, Il-Yang Pharmaceutical Co. Ltd., Accord Healthcare Inc., ARIAD Pharmaceuticals Inc., Orca Bio, and Bio-Path Holdings Inc.
Recent Strategic Moves Enhancing Market Competitiveness
In January 2025, Handa Therapeutics, a US-based pharmaceutical company, expanded its portfolio by acquiring the FDA-approved CML drug PHYRAGO (dasatinib) tablets for an undisclosed sum. This acquisition aims to strengthen Handa Therapeutics' position in oncology, particularly in hematologic malignancies, by broadening access to targeted therapies. The move is also expected to accelerate revenue growth through a product that has regulatory approval and an established market presence. Another notable player in the space is Nanocopoeia, LLC, a US-based research firm contributing to advancements in the field.
Innovative Trends Reshaping the Chronic Myeloid Leukemia Treatment Market
Leading companies in the CML treatment sector are increasingly focusing on integrating cutting-edge technologies to improve patient outcomes. For example, state-of-the-art mobile digital radiography systems equipped with AI capabilities and wireless flat-panel detectors are being developed to enhance diagnostic imaging. These innovations facilitate bedside imaging with high precision, improving efficiency and patient experience. An example is the DRX-Rise Mobile X-ray System launched by Carestream Health Inc. in May 2023. This system features a powerful lithium battery, in-bin detector charging, dual touchscreen displays for streamlined workflows, and AI-powered software to optimize image quality, minimize errors, and reduce radiation dose.
The DRX-Rise system is designed to be affordable and accessible, offering healthcare facilities an opportunity to upgrade their radiography capabilities without incurring heavy costs. Its quiet operation and agile maneuverability make it particularly suitable for sensitive and crowded environments such as ICUs and NICUs. These innovations highlight the market's movement toward combining advanced technology with user-friendly design to improve overall disease management.
Detailed Breakdown of Chronic Myeloid Leukemia Treatment Market Segments
This report segments the chronic myeloid leukemia treatment market into several categories for a detailed understanding:
1) By Type of Treatment: Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy, and Stem Cell Transplant
2) By Drug Class: Tyrosine Kinase Inhibitors, Antimetabolites, and Other Drug Types
3) By Application Setting: Hospitals, Clinics, and Other Medical Facilities
4) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
Further classification includes:
- Within Targeted Therapy: Tyrosine Kinase Inhibitors (TKIs), BCR-ABL Inhibitors, Monoclonal Antibody Therapy, and Signal Transduction Inhibitors
- Within Chemotherapy: Alkylating Agents, Antimetabolites, Anthracyclines, and Combination Chemotherapy Regimens
- Radiation Therapy subtypes cover External Beam Radiation Therapy, Total Body Irradiation, and Radioimmunotherapy
- Splenectomy is divided into Partial and Total Splenectomy
- Stem Cell Transplant includes Allogeneic Hematopoietic Stem Cell Transplant and Autologous Stem Cell Transplant
This comprehensive segmentation illustrates the wide array of therapeutic options and delivery methods available in the CML treatment landscape, reflecting ongoing advancements and tailored approaches in managing this disease.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Chronic Myeloid Leukemia (CML) Treatment Market here
News-ID: 4463869 • Views: …
More Releases from The Business Research Company
Segment Analysis and Major Growth Areas in the Computerized Physician Order Entr …
The computerized physician order entry (CPOE) market is set to experience significant growth as healthcare systems continue to adopt advanced digital technologies. Increasing investment in smart hospital infrastructure and the rising need for real-time clinical decision support are driving this momentum. Let's explore the market size forecasts, key players, emerging trends, and segmentation details shaping the future of this vital healthcare IT sector.
Projected Market Size and Growth Outlook for Computerized…
Emerging Growth Patterns Driving Rapid Expansion in the Cell Harvesting Market
The cell harvesting market is on track for significant expansion over the coming years, driven by technological advancements and increasing demand in biopharmaceutical manufacturing. As the industry evolves, innovations and strategic investments are shaping its future trajectory, making it a critical area to watch in the life sciences sector.
Projected Growth and Market Size of the Cell Harvesting Market
The cell harvesting market is anticipated to experience strong growth, reaching a…
Leading Companies Fueling Growth and Innovation in the Clinical Trial Support Se …
The clinical trial support services sector is evolving rapidly as the demand for efficient, technology-driven solutions intensifies. With a growing emphasis on digital tools and streamlined processes, this market is set to experience notable expansion over the coming years. Let's explore the market's size, key players, emerging trends, and segmentation in greater detail.
Projected Market Size and Growth Expectations for Clinical Trial Support Services
The clinical trial support services market is…
Key Factors and Emerging Trends Shaping the Clinical Trial Patient Recruitment S …
The clinical trial patient recruitment services market is gaining considerable traction as the demand for efficient and patient-focused clinical trials increases globally. With innovations in digital tools and evolving trial methodologies, this sector is set to experience robust growth in the coming years. Below, we explore the market's projected size, leading companies, emerging trends, and key segmentations shaping its future.
Projected Market Size and Growth Outlook for Clinical Trial Patient Recruitment…
More Releases for Pharmaceutical
Metronidazole Market 2023 Latest Innovations and Outlook By Players - Hongyuan P …
The Metronidazole Market 2023 study focuses on a global evaluation of information from the most recent market developments. The purpose of MarketsandResearch.biz is to offer the company's customers a comprehensive market overview to formulate development plans.
Designing of the report is done with the help of infographics, charts, and graphs. The report initially analyzes the various segments of the global Metronidazole market in a brief manner, which includes product types, applications.…
Hyperthyroidism Treatment Market Analytical Overview and Future | Merck, Herbran …
The Hyperthyroidism Treatment market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with development…
Mevastatin Market Is Booming Worldwide |Zhejiang Hisun Pharmaceutical, Guangdong …
Global Mevastatin Market Size research report 2022 offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. This study provides information about the sales and revenue during the historic and forecasted period of (2022 to 2028). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for…
Global Specialty Pharmaceutical Market Driving Future Growth on Specialty Pharma …
Global Specialty Pharmaceutical Industry Synopsis:
The Specialty Pharmaceutical Market report provides a detailed analysis of this business space. The market is analyzed in terms of production as well as consumption. Based on the production aspect, the report includes particulars pertaining to the manufacturing processes of the product, alongside revenue and gross margins of the respective manufacturers.
The Global Specialty Pharmaceutical Market will reach xxx Million USD in 2020 with CAGR xx%…
Metronidazole Market to 2023 (+5% CAGR Expected) Top Player Profiles – Hongyua …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in…
Metronidazole Market by Top Key Participant Hongyuan Pharmaceutical, Yinhe Aarti …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.researchbeam.com/global-metronidazole-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/request-sample?utm_source=Anil
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in North…
